58  Total SME IPOs listed in 2025

2,593.84 Crs.  Total funds raised in 2025

40  SME IPOs listed with Gain in 2025

18  SME IPOs listed with loss in 2025

58  Total SME IPOs listed in 2025

2593.84 Crs.  Total funds raised in 2025

40  SME IPOs listed with Gain in 2025

18  SME IPOs listed with loss in 2025

58  Total SME IPOs listed in 2025

2593.84 Crs.  Total funds raised in 2025

40  SME IPOs listed with Gain in 2025

18  SME IPOs listed with loss in 2025

58  Total SME IPOs listed in 2025

2593.84 Crs.  Total funds raised in 2025

40  SME IPOs listed with Gain in 2025

18  SME IPOs listed with loss in 2025

Sai Life Sciences Limited IPO (Sai Life Sciences IPO) Details

Sai Life Sciences Limited is an Chemical based company, located in Hyderabad, Sai Life Sciences Limited IPO size was 3042.62 Cr. and was issued at 549.00 per share. The share of Sai Life Sciences Limited were listed at 764.65 per share and are currently trading at 721.50 per share.

Type :
Sub Sector : Offers Tailor-made Services To Biotech Firms And Global Pharma Companies.
MainBoard IPO

Financial Summary (at the time of ipo, on annualised basis)

Revenue :
1386.70 Cr.

PAT :
56.02 Cr.

Pricing Report

Issue Price :
549.00

Listing Price :
764.65

Current Market Price :
721.50

Issue Price vs CMP :
172.5 (31.42%)

listing Price vs CMP :
43.15 (5.64%)

Performance Report (CAGR* wise)

CAGR : 126.47
-ve 0 6 9 12+
Above Average

*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.

*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.

About Sai Life Sciences

Company Information
Sai Life Sciences Limited, an innovator-focused ,contract research, development, and manufacturing organization (“CRDMO”). They provide end-to-end services across the drug discovery, development, and manufacturing value chain, for small molecule new chemical entities (“NCE”),to global pharmaceutical innovator companies and biotechnology firms. They possess both (a) discovery /contract research (“CRO”) and(b)chemistry, manufacturing, and control (“CMC”)/ contract development and manufacturing organization (“CDMO”) capabilities. They are the fastest-growing Indian CRDMO samong listed Indian peers in terms of revenue CAGR as well as EBITDACAGR from Financial Year 2022 to Financial Year 2024.(Source: F&S Report) Their CRDMO
Show More
Object of Issue
  • Repayment/prepayment, in full or part,of all or certain outstanding borrowing savailed by their Company
  • General corporate purpose

Sai Life Sciences MainBoard IPO Details (at the time of IPO)

IPO Type :
Book Building
IPO Date :
Dec, 2024
IPO Size :
3042.62 Cr.
Market Cap :
11418.63 Cr.   
IPO Subscription :
10.27 X     
PE Multiple :
203.82
Merchant Banker :
Iifl Securities Limited
IPO Registrar:
KFin Technologies Limited
Thinking of
Listing Your Business through
SME IPO?
We can Help!
Contact Us Today

See Other MainBoard IPOs in Hyderabad

Quality Power Electrical Equipments Limited

  Manufactures critical high-voltage equipment for High Voltage Direct Current (HVDC) and Flexible AC Transmission Systems (FACTS) networks, enabling energy transition from renewable sources to power gr

  Sangli


Hexaware Technologies Limited

  business of global digital and technology services with artificial intelligence.

  Mumbai


Ajax Engineering Limited

  SLCM machinery that are widely used in infra developments

  Bangalore


Dr Agarwals Health Care Limited

  comprehensive range of eye care services

  Chennai


Denta Water and Infra Solutions Limited

  water and infrastructure solutions company

  Bangalore


Peer Companies Of This Sector

FAQs

Sai Life Sciences operates in Chemical and Offers Tailor-made Services To Biotech Firms And Global Pharma Companies.. The Issue is listed on BSE,NSE in Dec, 2024. Sai Life Sciences IPO size was 3042.62 Cr. with Issue price of 549.00 .

Merchant Banker(s) of Sai Life Sciences IPO: Iifl Securities Limited , Jefferies India Private Limited , Kotak Mahindra Capital Company Limited , Morgan Stanley India Company Private Limited

Sai Life Sciences IPO subscription was 10.27 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.

Sai Life Sciences IPO listed at a listing price of 764.65 against the offer price of 549.00.

The current market price of Sai Life Sciences is 721.50.

Services

IPO Advisory
IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Readiness
IPO Readiness
IPO Roadmap by improving Business Efficiencies, Financial Parameters and Corporate Structure to become IPO ready.
Fund Raising
Fund Raising
Fuelling a company's growth through Pre IPO Fund Raise, Private Equity, and Angel Investing.
SME : Business Scaling
SME Business Upscaling
Provide support to build a scalable SME business by unleashing the SME potential.
Post IPO Montoring
Post IPO Mentoring
Assisting with post IPO regulatory requirements and Performance Monitoring to achieve the milestone of Mainboard migration.

Thinking of
Listing Your Business through SME IPO?

We can help! Contact Us

Why Us?

  • Leading portal for IPOs
  • End to End Solutions
  • Known for Transparency